{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:09:10Z","timestamp":1776362950400,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:00:00Z","timestamp":1608854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ihj.2020.12.013","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T21:44:07Z","timestamp":1609278247000},"page":"135-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["ACPTI study: Being positive in a negative situation is not naivety \u2013 Trimetazidine still has role in symptomatic CAD patients"],"prefix":"10.1016","volume":"73","author":[{"given":"Jamshed","family":"Dalal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2020.12.013_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.12.013_bib2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2020.12.013_bib3","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","article-title":"Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial","volume":"392","author":"Stone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2020.12.013_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2020.12.013_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2020.12.013_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1472-8206.2003.00154.x","article-title":"Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine","volume":"17","author":"Stanley","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ihj.2020.12.013_bib7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1185\/030079904X2637","article-title":"Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study","volume":"20","author":"Ruzyllo","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ihj.2020.12.013_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00045391-200501000-00006","article-title":"Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study","volume":"12","author":"Chazov","year":"2005","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.ihj.2020.12.013_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijcard.2012.11.001","article-title":"Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study","volume":"168","author":"Vitale","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2020.12.013_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s12325-017-0490-2","article-title":"Real-world evidence for the antianginal efficacy of trimetazidine from the Russian observational CHOICE-2 study","volume":"34","author":"Glezer","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.ihj.2020.12.013_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ihj.2016.09.009","article-title":"Premature coronary artery disease in India: coronary artery disease in the young (CADY) registry","volume":"69","author":"Iyengar","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2020.12.013_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2020.12.013_bib13","first-page":"1473","article-title":"Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention","volume":"9","author":"Koskinas","year":"2016","journal-title":"J Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.ihj.2020.12.013_bib14","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Members","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.12.013_bib15","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2020.12.013_bib16","first-page":"986","article-title":"Stress testing after complete and successful coronary revascularization","volume":"32","author":"Huqi","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2020.12.013_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2020.12.013_bib18","first-page":"989","article-title":"Thermodilutional confirmation of coronary microvascular dysfunction in patients with recurrent angina after successful percutaneous coronary intervention","volume":"31","author":"Li","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ihj.2020.12.013_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2020.12.013_bib20","article-title":"Effect of trimetazidine in patients undergoing percutaneous coronary intervention: a meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ihj.2020.12.013_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.amjcard.2014.04.052","article-title":"Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention","volume":"114","author":"Shehata","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2020.12.013_bib22","first-page":"58","article-title":"Cardioprotective effects of oral trimetazidine in diabetic patients with anterior wall myocardial infarction treated with thrombolysis","volume":"5","author":"Shehata","year":"2014","journal-title":"Cardiol Res"},{"key":"10.1016\/j.ihj.2020.12.013_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40261-014-0170-9","volume":"34","author":"Xu","year":"2014","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.ihj.2020.12.013_bib24","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1016\/j.ihj.2018.10.415","article-title":"Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention\u2013induced myocardial injury","volume":"70","author":"Kazmi","year":"2018","journal-title":"Indian Heart J"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483220304636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483220304636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:55:18Z","timestamp":1758081318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483220304636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0019483220304636"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2020.12.013","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACPTI study: Being positive in a negative situation is not naivety \u2013 Trimetazidine still has role in symptomatic CAD patients","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2020.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}